Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Allergy. 2020 Jul;75(7):1546-1554. doi: 10.1111/all.14336.

Abstract

The current COVID‐19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen‐specific immunotherapy (AIT) is one of the most important treatment options for IgE‐mediated allergies and is based on immunological effects on the diseased patient

Keywords: allergy treatment; immunotherapy clinical; immunotherapy vaccines and mechanisms.

MeSH terms

  • Allergists / psychology
  • Asthma / complications
  • Asthma / therapy*
  • Betacoronavirus / genetics*
  • Betacoronavirus / immunology*
  • CD8-Positive T-Lymphocytes / immunology
  • Coronavirus Infections / complications
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology
  • Eosinophils / immunology
  • Humans
  • Immunoglobulin E / metabolism
  • Immunoglobulin M / metabolism
  • Infection Control / methods*
  • Pandemics / prevention & control*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / virology
  • Rhinitis, Allergic / complications
  • Rhinitis, Allergic / therapy*
  • Sublingual Immunotherapy / methods*
  • Th2 Cells / immunology

Substances

  • Immunoglobulin M
  • Immunoglobulin E

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2